Building Resilience in the Pharmaceutical Supply Chain: Lessons from the Pandemic
The COVID-19 pandemic created significant supply chain challenges as manufacturers and distribution channels shut down,…
A Closing Window for High-Impact Investments
In mid-July, we had a piece published in GovExec looking at how Federal leaders could…
